We named this practice after Venus — the brightest light in the sky and the only planet named after a woman. We did it because we know what it feels like to be at the edge of something important and not know which way to turn. Venara is the signal that says: you're not lost. You're just at the beginning.
Venus was the Roman goddess of beauty, prosperity, and victory. The brightest object in the sky after the sun and moon. The fixed point navigators looked to when they weren't sure where they were going. For thousands of years, it was the signal that said: you're not lost.
The name Venara carries that lineage forward. We're not Venus. We're what comes next — the practice named for that brightness, built to bring it to companies that need a reference point of their own.
We met in the trenches of a life sciences company that was trying to do something it had never done before — take a platform product to market, with thousands of SKUs in the catalog, no commercialization framework, and a team that was good but stretched.
We built it. The Stage-Gate process. The pricing model. The voice of customer framework. The portfolio rationalization. The launch itself, cross-functionally, from readiness through market entry. And by the end, the company had a foundation that hadn't existed when we started.
Somewhere in the middle of all that, we realized two things. First — that what we'd built together wasn't a one-time deliverable. It was a way of working that other companies desperately needed and couldn't easily find. Second — that we worked extraordinarily well together. Different skills, complementary strengths, the same standard for what "done right" actually means.
So we built Venara — for the companies that need what we know how to do, in the language they speak, at the moment everything is about to change.
Venara is not a generalist consultancy. We're operators who built things at the enterprise level and now bring that experience to companies who need it most — fractionally, bilingually, and without pretending the work is simple.
Deb brings deep expertise in commercialization strategy, product management, operations, and marketing for technical and life sciences companies. She has built commercialization processes from scratch, rationalized portfolios of thousands of SKUs, implemented Stage-Gate frameworks, launched over 100 new products, and led go‑to‑market strategy for offerings that did not exist a year before launch. Her track record includes leading spatial biology product portfolios at Enzo Biochem Inc., where she spearheaded 20 campaigns across drug discovery and disease areas, partnered with cross‑functional teams, and delivered webinars, oral and poster presentations, and strategic marketing initiatives that elevated brand visibility and market reach.
A multilingual science storyteller fluent in English, Korean, Spanish, and French, with beginner Portuguese, Deb is as comfortable in a lab as she is in an executive boardroom. Her path started with a Journalism degree from Hofstra University, where she honed publishing and communication skills, followed by a degree in Clinical Laboratory Science and a PhD in Molecular and Cellular Biology from Stony Brook University. She gained hands‑on clinical experience in hematology, immunohematology, coagulation, microbiology, parasitology, and chemistry before moving into industry roles that demanded both scientific rigor and commercial judgment.
At Venara, Deb provides on‑demand C‑suite guidance in commercialization roadmaps, operational efficiency, product lifecycle management, and targeted marketing strategies for startups, mid‑sized companies, and non‑profits in and beyond life sciences. She draws on deep expertise in science, data analysis, business intelligence, and AI‑driven tools to help organizations accelerate go‑to‑market execution, optimize operations, and scale products in competitive markets. With certifications in agile project management, digital marketing strategy, and AI agents, she combines rigorous scientific training with modern business acumen and the narrative skills earned from her journalism background.
Miriam brings over two decades of experience in life sciences commercialization, brand building, and strategic marketing leadership to Venara Advisory. A bilingual commercial strategist fluent in English and Spanish, she translates complex science into clear positioning and actionable market strategy across biotech, pharmaceutical, and bioprocessing sectors. Her foundation includes a BS in Biochemistry and Hispanic Literature from Stony Brook University and an MS in Pharmaceutical Sciences from St. John's University, where she was a member of the Rho Chi Honor Society.
She has led commercial strategy and brand development from multiple vantage points: over 11 years as AVP of Marketing at Enzo Biochem Inc., where she built campaigns that elevated brand visibility and drove growth across diagnostics and life sciences products; sales experience at Pall Corporation, driving revenue growth across life sciences and bioprocessing accounts; director‑level marketing roles at Sartorius; and executive leadership as Executive Director of the Society for Biological Engineering (SBE) at AIChE, where she led strategic initiatives for the global bioengineering community. Since 2011, she has also served as a Board Member at Hyrian, providing executive advisory and brand management guidance to support talent acquisition and workforce strategy in tech and life sciences.
At Venara, Miriam provides fractional executive guidance in commercialization strategy, brand development, marketing operations, and team building for startups, mid‑sized companies, and non‑profit organizations in life sciences and adjacent sectors. She brings deep experience in product launches, market positioning, go‑to‑market execution, and strategic partnerships, helping organizations scale products, optimize commercial operations, and build high‑performing commercial and marketing teams. With multiple publications in bioprocessing and life sciences, certifications in project management and AI for data analysis, and a track record as a builder of companies and brands, she combines scientific rigor with modern marketing acumen and grounded leadership.
A 30-minute conversation. No pitch. No proposal. Just see if we're the right fit for what you're trying to do.
Start the Conversation